Rudy Tedja1, Jean Wentink2, John C O'Horo3, Rodney Thompson3, Priya Sampathkumar3. 1. 1Division of Critical Care Medicine,Mayo Clinic,Rochester,Minnesota. 2. 3Infection Prevention and Control,Mayo Clinic,Rochester,Minnesota. 3. 2Division of Infectious Disease,Mayo Clinic,Rochester,Minnesota.
Abstract
OBJECTIVE: To delineate the epidemiology of catheter-associated urinary tract infections (CAUTIs) and to better understand the value of urine cultures for evaluation of fever in the intensive care unit (ICU) setting DESIGN: Two-year retrospective review (2012-2013) SETTING: A single tertiary center with 1,200 hospital beds and 158 adult ICU beds PATIENTS: ICU patients with a CAUTI event METHODS: The cohort was identified from a prospective infection prevention database. Charts were reviewed to characterize the patients. CAUTI rates and device utilization ratio (DUR) were calculated. Clinical outcomes were recorded. RESULTS: A total of 105 CAUTIs were identified using the National Health and Safety Network (NHSN) definition. Fever was the primary indication for obtaining urine culture in 102 patients (97%). Of these 105 patients, 51 (51%) had an alternative infection to explain the fever, with pneumonia (55%) being the most common followed by bloodstream infection (22%). A total of 18 patients (18%) had fever due to noninfectious cause, and 32 patients (32%) had no alternative explanation. Of these, 66% received appropriate empiric antimicrobial therapy, but no targeted therapy changes were made based on urine culture results. The other 34% did not receive antimicrobial therapy at all. Only 6% of all CAUTIs resulted in blood cultures positive for the same organism within 2 days. The urinary tract was not definitely established as the source of bloodstream infection. CONCLUSIONS: Urine cultures obtained for evaluation of fever form the basis for identification of CAUTIs in the ICU. However, most patients with CAUTIs are eventually found to have alternative explanations for fever. CAUTI is associated with a low complication rate.
OBJECTIVE: To delineate the epidemiology of catheter-associated urinary tract infections (CAUTIs) and to better understand the value of urine cultures for evaluation of fever in the intensive care unit (ICU) setting DESIGN: Two-year retrospective review (2012-2013) SETTING: A single tertiary center with 1,200 hospital beds and 158 adult ICU beds PATIENTS: ICU patients with a CAUTI event METHODS: The cohort was identified from a prospective infection prevention database. Charts were reviewed to characterize the patients. CAUTI rates and device utilization ratio (DUR) were calculated. Clinical outcomes were recorded. RESULTS: A total of 105 CAUTIs were identified using the National Health and Safety Network (NHSN) definition. Fever was the primary indication for obtaining urine culture in 102 patients (97%). Of these 105 patients, 51 (51%) had an alternative infection to explain the fever, with pneumonia (55%) being the most common followed by bloodstream infection (22%). A total of 18 patients (18%) had fever due to noninfectious cause, and 32 patients (32%) had no alternative explanation. Of these, 66% received appropriate empiric antimicrobial therapy, but no targeted therapy changes were made based on urine culture results. The other 34% did not receive antimicrobial therapy at all. Only 6% of all CAUTIs resulted in blood cultures positive for the same organism within 2 days. The urinary tract was not definitely established as the source of bloodstream infection. CONCLUSIONS: Urine cultures obtained for evaluation of fever form the basis for identification of CAUTIs in the ICU. However, most patients with CAUTIs are eventually found to have alternative explanations for fever. CAUTI is associated with a low complication rate.
Authors: John J Halperin; Stephen Moran; Doriann Prasek; Ann Richards; Charlene Ruggiero; Christina Maund Journal: Neurocrit Care Date: 2016-10 Impact factor: 3.210
Authors: Reham M Goda; Ahmed M El-Baz; Eman M Khalaf; Nada K Alharbi; Tarek A Elkhooly; Mohamed M Shohayeb Journal: Antibiotics (Basel) Date: 2022-04-08
Authors: Carmin M Kalorin; Jessica M Dixon; Lucy V Fike; J West Paul; Neal K Chawla; David Kirk; Patricia C Woltz; Nimalie D Stone Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2022-09-26